| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Net loss | -25,399 | -7,640 | -6,436 | -10,592 |
| Foreign currency translation | -6 | 0 | 3 | 14 |
| Comprehensive loss | -25,405 | -7,640 | -6,433 | -10,578 |
| Net loss per common share - basic and diluted (in dollars per share) | -0.68 | -0.49 | -0.69 | -2.85 |
| Weighted average common shares outstanding, basic and diluted (in shares) | 37,304,455 | 15,526,401 | 9,343,771 | 3,714,278 |
Moleculin Biotech, Inc. (MBRX)
Moleculin Biotech, Inc. (MBRX)